G207
UAB 1472
Phase 1 mab completed
Quick answer
G207 for Supratentorial Neoplasms, Malignant is a Phase 1 program (mab) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Supratentorial Neoplasms, Malignant
- Phase
- Phase 1
- Modality
- mab
- Status
- completed